Place of magnesium drugs in pregnant women with cardiovascular disease
| Autor: | R. I. Stryuk |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | Медицинский совет, Vol 0, Iss 9, Pp 100-105 (2015) |
| Druh dokumentu: | article |
| ISSN: | 2079-701X 2658-5790 |
| DOI: | 10.21518/2079-701X-2015-9-100-105 |
| Popis: | By now there is a substantial evidence on the role of magnesium deficiency, which can occur during pregnancy even in healthy women in case of its insufficient intake through food, in the deterioration of the clinical condition and obstetric complications, especially in patients with cardiovascular disease. Therefore, complex preventive therapy which apart from treatment of hypertension and autonomic dysfunction with mitral valve prolapse, includes oral organic magnesium formulations (lactate, citrate, pidolate) in combination with pyridoxine to replenish magnesium deficiency in these patients has a pronounced positive effect both on the mother, the fetus, and the course of pregnancy. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|